Story perspectives
New Drug May Slash Breast Cancer Risk in High-Risk Women
11/6/2025
1 of 1
Story summary
- University of Manchester researchers found that ulipristal acetate may prevent breast cancer in women at high genetic risk.
- The trial involved 24 women aged 34 to 44 who took the drug for 12 weeks.
- Results showed reduced breast density and tissue changes that could lower cancer risk.
- Lead author Dr. Sacha Howell emphasized targeting progesterone in breast cancer prevention.
- The study was published in Nature.
